That stopped working for me a few years ago.
September 6
I am on intravenous Cosentyx.
September 6
Great question! PsA often starts in just a few joints (4 or fewer) before potentially spreading. The small joints tend to be hit first, but it really can vary from person to person.
Common early targets include:
- Fingers and toes — sometimes causing a sausage-like swelling called dactylitis
- Heels and feet — especially Show Full Answer
Great question! PsA often starts in just a few joints (4 or fewer) before potentially spreading. The small joints tend to be hit first, but it really can vary from person to person.
Common early targets include:
- Fingers and toes — sometimes causing a sausage-like swelling called dactylitis
- Heels and feet — especially the Achilles tendon and the bottom of the foot
- Knees — often feeling hot, stiff, or painful
- Elbows and shoulders — often linked to enthesitis (where tendons meet bone) As for progression, PsA doesn't follow a perfectly predictable path. It can stay mild or advance to affect more joints over time. If it progresses, the spine, hips, and larger joints can become involved.
The good news? Being on Skyrizi (risankizumab) is a proactive step. Biologics have been shown to lower the risk of PsA worsening and can slow joint damage. Early and consistent treatment is one of the best tools available.
It's worth keeping an open conversation with your rheumatologist about any new or changing joint symptoms, especially if some areas aren't improving as expected.
September 6
Join
Your Privacy Choices
